MyFinsight
Home
Blog
About
Proceeds from issuance of
common stock and...
$4,500K
Proceeds from issuance of
common stock under the...
$21K
Net cash provided by
financing activities
$4,020K
Canceled cashflow
$501K
Net decrease in
cash, cash...
-$5,624K
(57.48%↑ Y/Y)
Canceled cashflow
$4,020K
Stock-based compensation
$815K
(-40.03%↓ Y/Y)
Prepaid expenses and
other current assets
-$34K
(62.22%↑ Y/Y)
Payroll liabilities
$29K
(103.59%↑ Y/Y)
Depreciation
$4K
(-50.00%↓ Y/Y)
Offering costs for common
stock and warrant...
$501K
Net cash used in
operating activities
-$9,644K
(27.04%↑ Y/Y)
Canceled cashflow
$882K
Net loss
-$8,491K
(43.92%↑ Y/Y)
Accrued expenses
-$1,427K
(-211.40%↓ Y/Y)
Accounts payable
-$593K
(-144.55%↓ Y/Y)
Other current
liabilities
-$15K
(-130.61%↓ Y/Y)
Back
Back
Cash Flow
ATOSSA THERAPEUTICS, INC. (ATOS)
ATOSSA THERAPEUTICS, INC. (ATOS)
source: myfinsight.com